By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Boiron S.A.

Boiron S.A. (0DTF.L)

LSE Currency in EUR
€22.15
-€0.20
-0.89%
Last Update: 17 Jul 2025, 07:00
€384.57M
Market Cap
0.00
P/E Ratio (TTM)
5.42%
Forward Dividend Yield
€22.15 - €56.50
52 Week Range

0DTF.L Stock Price Chart

Explore Boiron S.A. interactive price chart. Choose custom timeframes to analyze 0DTF.L price movements and trends.

There is nothing to show.

0DTF.L Company Profile

Discover essential business fundamentals and corporate details for Boiron S.A. (0DTF.L) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Pharmaceuticals

IPO Date

29 Jul 2008

Employees

2.47K

CEO

Thierry Boiron

Description

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary, proprietary, branded homeopathic medicines. Its branded homeopathic medicines include Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; and Sédatif PC to treat anxiety and emotional, and minor sleep disorders. The company's homeopathic medicines also comprise Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; and Homéovox for vocal disorders. In addition, it provides dietary supplement; Dermoplasmine stick, baume, and mousse to treat dry lips and skin; Mag' Nuit, a formula to fall asleep; Arnitrosium for joint pain; Castor Equi Boiron ointment for treatment of cracked skin; and Storinyl, a syrup to treat colds. Further, it offers herbal medicines, such as Canephron to increase the amount of urine and to improve urinary elimination; moisturizing baby milk; and medical devices, including a range of COVID self-tests and rapid antigenic tests. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.

0DTF.L Financial Timeline

Browse a chronological timeline of Boiron S.A. corporate events including earnings releases, dividend announcements, and stock splits.

Dividend declared on 3 Jun 2025

A dividend of €1.20 per share was announced, adjusted to €1.20. The dividend was paid on 5 Jun 2025.

Earnings released on 11 Apr 2025

EPS came in at €0.46, while revenue for the quarter reached €259.21M.

Earnings released on 19 Sept 2024

EPS came in at €0.19, while revenue for the quarter reached €228.35M.

Dividend declared on 3 Jun 2024

A dividend of €1.35 per share was announced, adjusted to €1.35. The dividend was paid on 5 Jun 2024.

Earnings released on 2 Apr 2024

EPS came in at €1.17, while revenue for the quarter reached €253.37M.

Dividend declared on 18 Oct 2023

A dividend of €10.36 per share was announced, adjusted to €10.36. The dividend was paid on 20 Oct 2023.

Earnings released on 30 Jun 2023

EPS came in at €0.89, while revenue for the quarter reached €239.88M.

Dividend declared on 31 May 2023

A dividend of €1.10 per share was announced, adjusted to €1.10. The dividend was paid on 2 Jun 2023.

Earnings released on 31 Dec 2022

EPS came in at €1.85, while revenue for the quarter reached €277.48M.

Earnings released on 30 Jun 2022

EPS came in at €0.72, while revenue for the quarter reached €256.76M, missing expectations by -0.01%.

Dividend declared on 1 Jun 2022

A dividend of €0.95 per share was announced, adjusted to €0.95. The dividend was paid on 3 Jun 2022.

Earnings released on 31 Dec 2021

EPS came in at €2.17, while revenue for the quarter reached €265.27M.

Earnings released on 30 Jun 2021

EPS came in at -€0.54, while revenue for the quarter reached €189.93M, beating expectations by +0.02%.

Earnings released on 31 Dec 2020

EPS came in at €1.55, while revenue for the quarter reached €259.95M.

0DTF.L Stock Performance

Access detailed 0DTF.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

There is nothing to show.
0DTF.L
Company Name
Exchange
Market Currency
Report Currency
Price
Price Change
Percentage Change
50-Day Average Price
200-Day Average Price
Trading Volume
Market Capitalization
0DTF.L
2025
2024
2023
2022
2021
Revenue
Gross Profit
Earnings Before Interest and Taxes (EBIT)
Net Income
Total Current Assets
Total Assets
Total Liabilities
Net Debt
Total Equity
Cash Flow from Operating
Cash Flow from Investing
Cash Flow from Financing
Free Cash Flow

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More